Departments of Medicine (T.B.P., D.K.M., N.A.Z., M.C.), Larner College of Medicine at the University of Vermont, Burlington, VT.
Department of Medicine, Beth Israel Lahey Clinic/Harvard Medical School, Boston, MA (S.P.J).
Hypertension. 2024 Jun;81(6):1244-1253. doi: 10.1161/HYPERTENSIONAHA.123.22714. Epub 2024 Mar 15.
Hypertension is a highly prevalent cardiovascular disease risk factor that may be related to inflammation. Whether adverse levels of specific inflammatory cytokines relate to hypertension is unknown. The present study sought to determine whether higher levels of IL (interleukin)-1β, IL-6, TNF (tumor necrosis factor)-α, IFN (interferon)-γ, IL-17A, and CRP (C-reactive protein) are associated with a greater risk of incident hypertension.
The REGARDS study (Reasons for Geographic and Racial Difference in Stroke) is a prospective cohort study that recruited 30 239 community-dwelling Black and White adults from the contiguous United States in 2003 to 2007 (visit 1), with follow-up 9 years later in 2013 to 2016 (visit 2). We included participants without prevalent hypertension who attended follow-up 9 years later and had available laboratory measures and covariates of interest. Poisson regression estimated the risk ratio of incident hypertension by level of inflammatory biomarkers.
Among 1866 included participants (mean [SD] aged of 62 [8] years, 25% Black participants, 55% women), 36% developed hypertension. In fully adjusted models comparing the third to first tertile of each biomarker, there was a greater risk of incident hypertension for higher IL-1β among White (1.24 [95% CI, 1.01-1.53]) but not Black participants (1.01 [95% CI, 0.83-1.23]) and higher TNF-α (1.20 [95% CI, 1.02-1.41]) and IFN-γ (1.22 [95% CI, 1.04-1.42]) among all participants. There was no increased risk with IL-6, IL-17A, or CRP.
Higher levels of IL-1β, TNF-α, and IFN-γ, representing distinct inflammatory pathways, are elevated in advance of hypertension development. Whether modifying these cytokines will reduce incident hypertension is unknown.
高血压是一种高发的心血管疾病风险因素,可能与炎症有关。目前尚不清楚特定炎症细胞因子的异常水平是否与高血压有关。本研究旨在确定白细胞介素(IL)-1β、IL-6、肿瘤坏死因子(TNF)-α、干扰素(IFN)-γ、IL-17A 和 C 反应蛋白(CRP)等炎症因子水平升高是否与高血压发病风险增加相关。
REGARDS 研究(中风地理和种族差异的原因)是一项前瞻性队列研究,于 2003 年至 2007 年(第 1 次访问)在美国连续的社区中招募了 30239 名黑人和白人成年人,9 年后于 2013 年至 2016 年(第 2 次访问)进行了随访。我们纳入了参加随访且在 9 年后有可用实验室检测结果和感兴趣的混杂因素的无高血压前期参与者。泊松回归估计了炎症生物标志物水平与新发高血压的风险比。
在 1866 名纳入的参与者中(平均[标准差]年龄 62[8]岁,25%为黑人,55%为女性),36%的人患有高血压。在比较每种生物标志物第三至第一三分位的完全调整模型中,白种人白细胞介素 1β(1.24[95%CI,1.01-1.53])而不是黑人(1.01[95%CI,0.83-1.23])、TNF-α(1.20[95%CI,1.02-1.41])和 IFN-γ(1.22[95%CI,1.04-1.42])水平较高与高血压发病风险较高相关。IL-6、IL-17A 或 CRP 水平无升高。
在高血压发病前,IL-1β、TNF-α 和 IFN-γ 等代表不同炎症途径的水平升高。尚不清楚是否可以通过调节这些细胞因子来降低高血压的发病率。